5% - 10% of all prostate cancers do not express PSMA.
The SABRE results are incredible.
- Forums
- ASX - By Stock
- Ann: SABRE topline results
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
2.52%
!
$2.24

5% - 10% of all prostate cancers do not express PSMA.The SABRE...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.24 |
Change
0.055(2.52%) |
Mkt cap ! $723.0M |
Open | High | Low | Value | Volume |
$2.18 | $2.32 | $2.17 | $5.355M | 2.376M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 43524 | $2.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.24 | 15492 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 37396 | 2.230 |
13 | 71500 | 2.220 |
12 | 67900 | 2.210 |
13 | 113410 | 2.200 |
8 | 222961 | 2.190 |
Price($) | Vol. | No. |
---|---|---|
2.240 | 16280 | 31 |
2.250 | 33838 | 33 |
2.260 | 12502 | 16 |
2.270 | 18718 | 19 |
2.280 | 22239 | 9 |
Last trade - 14.14pm 19/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
RML
RESOLUTION MINERALS LTD
Craig Lindsay, In-Country CEO
Craig Lindsay
In-Country CEO
SPONSORED BY The Market Online